“Fundraising is not just about money – it’s strategic thinking.”
So said Adv. Gary Copelovitz, Partner and Co – Head of the Technology & M&A Department at Lipa Meir & Co., who led the “Life Sciences Funding Forum – From Bench to Market” conference, collaboration with IATI – Israel Advanced Technology Industries which brought together the key players truly driving life sciences forward in Israel – creating a standout event for sharp insights and high-impact networking.
From the opening remarks by Yaacov Michlin, Chairman of MIXiii Health-Tech.IL, CEO at BioLight Life Sciences Ltd., who emphasized the critical link between entrepreneurship, technology, and investment – especially in today’s climate, to a compelling talk by Adv. Gary Copelovitz on funding strategy and deal maps, to a dynamic panel led by Adv. Tsahi Mishal on alternative financing channels, and finally to the closing VC panel moderated by Gary Copelovitz, featuring senior representatives from Peregrine Ventures, aMoon Fund, Alive, Almeda Ventures , and Israel Innovation Authority.
One message was clear- The future is here and Israeli innovation is leading the way.
A big thank you to our partners at IATI, to the exceptional speakers, the amazing crowd who joined us, and of course – to our Technology Department team.
Special shout-out to Adv. Gary Copelovitz, Partner and Head of Technology and M&A Department at our firm, and to Adv. Tsahi Mishal, Technology and M&A Department, for showing once again how law and business go hand in hand.